Recombinant multi-species FAM110B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FAM110B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Located in cytosol and mitochondrion. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 1700012H17Rik,5031405P22,C8orf72,FAM110B,Fam110b,Protein FAM110B

Target products collectionGo to FAM110B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13411-Ag-1/ GM-Tg-hg-IP13411-Ag-2 Human FAM110B protein Human
GM-Tg-rg-IP13411-Ag-1/ GM-Tg-rg-IP13411-Ag-2 Rat FAM110B protein Rat
GM-Tg-mg-IP13411-Ag-1/ GM-Tg-mg-IP13411-Ag-2 Mouse FAM110B protein Mouse
GM-Tg-cynog-IP13411-Ag-1/ GM-Tg-cynog-IP13411-Ag-2 Cynomolgus/Rhesus macaque FAM110B protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13411-Ag-1/ GM-Tg-felg-IP13411-Ag-2 Feline FAM110B protein Feline
GM-Tg-cang-IP13411-Ag-1/ GM-Tg-cang-IP13411-Ag-2 Canine FAM110B protein Canine
GM-Tg-bovg-IP13411-Ag-1/ GM-Tg-bovg-IP13411-Ag-2 Bovine FAM110B protein Bovine
GM-Tg-equg-IP13411-Ag-1/ GM-Tg-equg-IP13411-Ag-2 Equine FAM110B protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13411-Ag-1/ GM-Tg-hg-IP13411-Ag-2; GM-Tg-rg-IP13411-Ag-1/ GM-Tg-rg-IP13411-Ag-2;
GM-Tg-mg-IP13411-Ag-1/ GM-Tg-mg-IP13411-Ag-2; GM-Tg-cynog-IP13411-Ag-1/ GM-Tg-cynog-IP13411-Ag-2;
GM-Tg-felg-IP13411-Ag-1/ GM-Tg-felg-IP13411-Ag-2; GM-Tg-cang-IP13411-Ag-1/ GM-Tg-cang-IP13411-Ag-2;
GM-Tg-bovg-IP13411-Ag-1/ GM-Tg-bovg-IP13411-Ag-2; GM-Tg-equg-IP13411-Ag-1/ GM-Tg-equg-IP13411-Ag-2
Products Name FAM110B protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FAM110B
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FAM110B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.